Lee Jones – Founder, President and CEO of Rebiotix Inc, has over 30 years of experience in the medical technology industry in large and small companies and academia. She cofounded Rebiotix in 2011. Rebiotix is a clinical stage biotechnology company developing a new class of biologic drugs based on live human-derived microbes. Previously, she was Chief Administrative Officer of the Schulze Diabetes Institute at the University of Minnesota and is the former president and chief executive officer of Inlet Medical. Inlet Medical, a privately held medical device company, was sold to CooperSurgical in 2006. Prior to Inlet, she spent 14 years at Medtronic where she developed and commercialized several innovative products that opened up new markets for the company. Lee has served on several public and private boards and is currently on the board of Electromed Inc., on the University of Minnesota’s Office of Technology Commercialization advisory board, and on the board of MedicalAlley, an industry association. She is a member of the Sofia Angel Investment Fund and is an advisor to several small companies. Ms. Jones has a BS in Chemical Engineering from the University of Minnesota and an Executive Management degree from the Carlson School of Management at the University of Minnesota.